Annual report
3055.TEDINET S100YJPG
Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥303.7bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥289.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥275.4bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥262.6bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥248.4bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | ¥1.7bn | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥2.9bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.4bn | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.6bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.5bn | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.9bn | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.4bn | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.8bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.7bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.8bn | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.7bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥155.7bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥147.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥147.3bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥137.9bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥136.9bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥91.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥85.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥64.7bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥61.9bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥60.7bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥57.4bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥55.5bn | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥17.1bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥17.7bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥17.1bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥17.7bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.0bn | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥21.1bn | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.5bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥262m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.7bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥828m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.0bn | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥910m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥990m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥898m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥835m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥849m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥80.58 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.44 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.2 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.41 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.44 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,144.85 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,942.63 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,819.99 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,614.23 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,460.67 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 41.5% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.6% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 2.7% | 2025-04-01 → 2026-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.0% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 3.7% | 2023-04-01 → 2024-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.8% | 2022-04-01 → 2023-03-31v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2021-04-01 → 2022-03-31v | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,591 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 1,605 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 1,601 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 1,626 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 1,625 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥1.7bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥1.6bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥31m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥320m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥174m | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥411m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥472m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥799m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥289m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥467m | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥411m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥462m | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | ¥407m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥334m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥619m | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥44.5bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥43.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥44.3bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥44.4bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥44.5bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.0bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥1.3bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥42.6bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥41.7bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥42.7bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥42.9bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥42.9bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.8bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.1bn | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥22.15 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.19 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.39 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.36 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.27 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥20 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥17 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,070.67 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,984.17 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,986.27 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,955.09 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,900.56 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 95.6% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.0% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.5% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.8% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.5% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 1.1% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.0% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.8% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.4% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 24,400,000 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 24,400,000 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 61 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 59 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 58 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 63 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 62 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 103
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2025-04-01 → 2026-03-31 | ¥93m |
| Otherother segments | depreciation | 2025-04-01 → 2026-03-31 | ¥45m |
| Otherother segments | revenue | 2025-04-01 → 2026-03-31 | ¥1.8bn |
| Otherother segments | revenue external | 2025-04-01 → 2026-03-31 | ¥34m |
| Otherother segments | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥1.8bn |
| Otherother segments | segment assets | at 2026-03-31 | ¥44.6bn |
| Otherother segments | segment profit | 2025-04-01 → 2026-03-31 | ¥32m |
| Dispensing Industryreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥327m |
| Dispensing Industryreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥90m |
| Dispensing Industryreportable segment | employees | at 2026-03-31 | 293 pure |
| Dispensing Industryreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥12.6bn |
| Dispensing Industryreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥12.6bn |
| Dispensing Industryreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥10m |
| Dispensing Industryreportable segment | segment assets | at 2026-03-31 | ¥6.0bn |
| Dispensing Industryreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥103m |
| Information And Communication Technology Industryreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥20m |
| Information And Communication Technology Industryreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥28m |
| Information And Communication Technology Industryreportable segment | employees | at 2026-03-31 | 76 pure |
| Information And Communication Technology Industryreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2.7bn |
| Information And Communication Technology Industryreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥680m |
| Information And Communication Technology Industryreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥2.0bn |
| Information And Communication Technology Industryreportable segment | segment assets | at 2026-03-31 | ¥1.0bn |
| Information And Communication Technology Industryreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥201m |
| Medical Equipment Wholesale Industryreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥163m |
| Medical Equipment Wholesale Industryreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥257m |
| Medical Equipment Wholesale Industryreportable segment | employees | at 2026-03-31 | 426 pure |
| Medical Equipment Wholesale Industryreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥70.1bn |
| Medical Equipment Wholesale Industryreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥69.7bn |
| Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥446m |
| Medical Equipment Wholesale Industryreportable segment | segment assets | at 2026-03-31 | ¥28.2bn |
| Medical Equipment Wholesale Industryreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥899m |
| Nursing Industryreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥623m |
| Nursing Industryreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥236m |
| Nursing Industryreportable segment | employees | at 2026-03-31 | 264 pure |
| Nursing Industryreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥4.7bn |
| Nursing Industryreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥4.7bn |
| Nursing Industryreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥23m |
| Nursing Industryreportable segment | segment assets | at 2026-03-31 | ¥5.8bn |
| Nursing Industryreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥268m |
| Wholesaler Of Drugs Industryreportable segment | capex | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Wholesaler Of Drugs Industryreportable segment | depreciation | 2025-04-01 → 2026-03-31 | ¥637m |
| Wholesaler Of Drugs Industryreportable segment | employees | at 2026-03-31 | 462 pure |
| Wholesaler Of Drugs Industryreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥223.2bn |
| Wholesaler Of Drugs Industryreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥215.9bn |
| Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥7.3bn |
| Wholesaler Of Drugs Industryreportable segment | segment assets | at 2026-03-31 | ¥106.0bn |
| Wholesaler Of Drugs Industryreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2025-04-01 → 2026-03-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2025-04-01 → 2026-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2026-03-31 | ¥315.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2026-03-31 | ¥303.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥11.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2026-03-31 | ¥191.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2026-03-31 | ¥2.5bn |
| Otherother segments | capex | 2024-04-01 → 2025-03-31 | ¥33m |
| Otherother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥28m |
| Otherother segments | revenue | 2024-04-01 → 2025-03-31 | ¥1.8bn |
| Otherother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥57m |
| Otherother segments | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.7bn |
| Otherother segments | segment assets | at 2025-03-31 | ¥43.2bn |
| Otherother segments | segment profit | 2024-04-01 → 2025-03-31 | ¥325m |
| Dispensing Industryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥102m |
| Dispensing Industryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥80m |
| Dispensing Industryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12.8bn |
| Dispensing Industryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12.8bn |
| Dispensing Industryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥11m |
| Dispensing Industryreportable segment | segment assets | at 2025-03-31 | ¥6.1bn |
| Dispensing Industryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥105m |
| Information And Communication Technology Industryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥13m |
| Information And Communication Technology Industryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥26m |
| Information And Communication Technology Industryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.4bn |
| Information And Communication Technology Industryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥895m |
| Information And Communication Technology Industryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Information And Communication Technology Industryreportable segment | segment assets | at 2025-03-31 | ¥1.0bn |
| Information And Communication Technology Industryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥18m |
| Medical Equipment Wholesale Industryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥301m |
| Medical Equipment Wholesale Industryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥254m |
| Medical Equipment Wholesale Industryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥70.0bn |
| Medical Equipment Wholesale Industryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥69.5bn |
| Medical Equipment Wholesale Industryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥536m |
| Medical Equipment Wholesale Industryreportable segment | segment assets | at 2025-03-31 | ¥28.1bn |
| Medical Equipment Wholesale Industryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Nursing Industryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥152m |
| Nursing Industryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥230m |
| Nursing Industryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| Nursing Industryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| Nursing Industryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥10m |
| Nursing Industryreportable segment | segment assets | at 2025-03-31 | ¥5.6bn |
| Nursing Industryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥319m |
| Wholesaler Of Drugs Industryreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥2.0bn |
| Wholesaler Of Drugs Industryreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥525m |
| Wholesaler Of Drugs Industryreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥209.7bn |
| Wholesaler Of Drugs Industryreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥201.9bn |
| Wholesaler Of Drugs Industryreportable segment | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥7.8bn |
| Wholesaler Of Drugs Industryreportable segment | segment assets | at 2025-03-31 | ¥99.2bn |
| Wholesaler Of Drugs Industryreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥301.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥289.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2025-03-31 | ¥11.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥183.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,892
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)谷川良憲 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)渡邊 崇 | |
| Audit opinion consolidated (text) | FilingDateInstant | Text · Plus | |
| Key audit matters consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam consolidated (text) | FilingDateInstant | Text · Plus | |
| Short description kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)医薬品卸売事業の各支店の固定資産の減損の兆候の識別の妥当性 | |
| Description including reason kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Reference kam consolidated | FilingDateInstant_Row1Member | Original text (Japanese)注記事項「（重要な会計上の見積り）医薬品卸売事業に係る固定資産の減損」 | |
| Auditors response kam consolidated (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Other information consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information consolidated (text) | FilingDateInstant | Text · Plus | |
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)谷川良憲 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)渡邊 崇 | |
| Audit opinion non consolidated (text) | FilingDateInstant | Text · Plus | |
| Key audit matters non consolidated (text) | FilingDateInstant | Text · Plus | |
| Overview kam non consolidated (text) | FilingDateInstant | Text · Plus | |
| Other information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Fee related information non consolidated (text) | FilingDateInstant | Text · Plus | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior4YearDuration | 248369000000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration | 262554000000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration | 275364000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 289534000000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration | 303667000000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration | 3413000000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration | 3887000000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration | 3533000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 3637000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration | 2417000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior4YearDuration | 2804000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior3YearDuration | 2729000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior2YearDuration | 2175000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2472000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYearDuration | 1683000000 | JPY |
| Comprehensive income (5-year summary) | Prior4YearDuration | 1957000000 | JPY |
| Comprehensive income (5-year summary) | Prior3YearDuration | 2662000000 | JPY |
| Comprehensive income (5-year summary) | Prior2YearDuration | 4051000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 2035000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYearDuration | 3623000000 | JPY |
| Net assets (5-year summary) | Prior4YearInstant | 55543000000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant | 57443000000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant | 60684000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 61861000000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant | 64663000000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant | 136883000000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant | 137937000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |